Literature DB >> 33434353

Tract-specific analysis and neurocognitive functioning in sickle cell patients without history of overt stroke.

Yaqiong Chai1,2,3, Chaoran Ji1,2,4, Julie Coloigner1,5, Soyoung Choi6, Melissa Balderrama7,8, Chau Vu3, Benita Tamrazi2, Thomas Coates7,8, John C Wood5,7, Sharon H O'Neil7,9,10, Natasha Lepore1,2,3,7.   

Abstract

INTRODUCTION: Sickle cell disease (SCD) is a hereditary blood disorder in which the oxygen-carrying hemoglobin molecule in red blood cells is abnormal. SCD patients are at increased risks for strokes and neurocognitive deficit, even though neurovascular screening and treatments have lowered the rate of overt strokes. Tract-specific analysis (TSA) is a statistical method to evaluate microstructural WM damage in neurodegenerative disorders, using diffusion tensor imaging (DTI).
METHODS: We utilized TSA and compared 11 major brain WM tracts between SCD patients with no history of overt stroke, anemic controls, and healthy controls. We additionally examined the relationship between the most commonly used DTI metric of WM tracts and neurocognitive performance in the SCD patients and healthy controls.
RESULTS: Disruption of WM microstructure orientation-dependent metrics for the SCD patients was found in the genu of the corpus callosum (CC), cortico-spinal tract, inferior fronto-occipital fasciculus, right inferior longitudinal fasciculus, superior longitudinal fasciculus, and left uncinate fasciculus. Neurocognitive performance indicated slower processing speed and lower response inhibition skills in SCD patients compared to controls. TSA abnormalities in the CC were significantly associated with measures of processing speed, working memory, and executive functions.
CONCLUSION: Decreased DTI-derived metrics were observed on six tracts in chronically anemic patients, regardless of anemia subtype, while two tracks with decreased measures were unique to SCD patients. Patients with WMHs had more significant FA abnormalities. Decreased FA values in the CC significantly correlated with all nine neurocognitive tests, suggesting a critical importance for CC in core neurocognitive processes.
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Entities:  

Keywords:  microstructural damage; neurocognitive; sickle cell disease; tract-specific analysis; white matter

Year:  2021        PMID: 33434353      PMCID: PMC7994688          DOI: 10.1002/brb3.1978

Source DB:  PubMed          Journal:  Brain Behav            Impact factor:   2.708


  80 in total

1.  Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease.

Authors:  J Schatz; R T Brown; J M Pascual; L Hsu; M R DeBaun
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

Review 2.  Executive function and the frontal lobes: a meta-analytic review.

Authors:  Julie A Alvarez; Eugene Emory
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

3.  Examination of processing speed deficits in multiple sclerosis using functional magnetic resonance imaging.

Authors:  Helen M Genova; Frank G Hillary; Glenn Wylie; Bart Rypma; John Deluca
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

4.  Vascular occlusion and ischemic infarction in sickle cell disease.

Authors:  P KIMMELSTEIL
Journal:  Am J Med Sci       Date:  1948-07       Impact factor: 2.378

Review 5.  Sickle-cell disease.

Authors:  David C Rees; Thomas N Williams; Mark T Gladwin
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

6.  Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.

Authors:  Françoise Bernaudin; Suzanne Verlhac; Cécile Arnaud; Annie Kamdem; Sylvie Chevret; Isabelle Hau; Lena Coïc; Emmanuella Leveillé; Elisabeth Lemarchand; Emmanuelle Lesprit; Isabelle Abadie; Nadia Medejel; Fouad Madhi; Sophie Lemerle; Sandra Biscardi; Josiane Bardakdjian; Frédéric Galactéros; Martine Torres; Mathieu Kuentz; Christelle Ferry; Gérard Socié; Philippe Reinert; Christophe Delacourt
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

7.  Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition.

Authors:  R Scott Mackin; Philip Insel; Diana Truran; Elliot P Vichinsky; Lynne D Neumayr; F D Armstrong; Jeffrey I Gold; Karen Kesler; Joseph Brewer; Michael W Weiner
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

8.  Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.

Authors:  Veronica van der Land; Henri J M M Mutsaerts; Marc Engelen; Harriët Heijboer; Mark Roest; Martine J Hollestelle; Taco W Kuijpers; Paul J Nederkoorn; Marjon H Cnossen; Charles B L M Majoie; Aart J Nederveen; Karin Fijnvandraat
Journal:  Br J Haematol       Date:  2015-10-22       Impact factor: 6.998

9.  Cognitive function correlates with frontal white matter apparent diffusion coefficients in patients with leukoaraiosis.

Authors:  Miguel Viana-Baptista; Paulo Bugalho; Constança Jordão; Naide Ferreira; Alavro Ferreira; Mário Forjaz Secca; José António Esperança-Pina; José Manuel Ferro
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

10.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

View more
  6 in total

1.  Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study.

Authors:  Hanne Stotesbury; Patrick W Hales; Anna M Hood; Melanie Koelbel; Jamie M Kawadler; Dawn E Saunders; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba P D Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  Front Physiol       Date:  2022-05-03       Impact factor: 4.755

2.  Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias.

Authors:  Chau Vu; Adam Bush; Soyoung Choi; Matthew Borzage; Xin Miao; Aart J Nederveen; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2021-05-12       Impact factor: 13.265

3.  Tract-specific analysis and neurocognitive functioning in sickle cell patients without history of overt stroke.

Authors:  Yaqiong Chai; Chaoran Ji; Julie Coloigner; Soyoung Choi; Melissa Balderrama; Chau Vu; Benita Tamrazi; Thomas Coates; John C Wood; Sharon H O'Neil; Natasha Lepore
Journal:  Brain Behav       Date:  2021-01-12       Impact factor: 2.708

4.  Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Jonathan D Clayden; Dawn E Saunders; Anna M Hood; Melanie Koelbel; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba P D Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

5.  Chronic anemia: The effects on the connectivity of white matter.

Authors:  Clio González-Zacarías; Soyoung Choi; Chau Vu; Botian Xu; Jian Shen; Anand A Joshi; Richard M Leahy; John C Wood
Journal:  Front Neurol       Date:  2022-07-26       Impact factor: 4.086

6.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.